LONG-TERM ADMINISTRATION OF TAMSULOSIN INCREASE APOPTOSIS ON PROSTATE CELL OF BPH PATIENT: STUDY ON TGF-ß1, SMAD-4, AND NF- KB
##plugins.themes.bootstrap3.article.main##
##plugins.themes.bootstrap3.article.sidebar##
Abstract
Objective: In this study we aimed to know further mechanism and relation between the long-term usage of tamsulosin with the apoptotic mechanism on prostatic cells of BPH patients qualitatively. Material & Methods: A Case-control study from prostate resection specimens. Subjects were 20 male who underwent the TUR-P procedure, were divided into two groups equally, a group who got long-term administration of tamsulosin 0.4 mg, and one without tamsulosin. TGF-β1 and Smad-4 expression was measured by Enzyme-Linked Immunosorbent Assay (ELISA), meanwhile expression of NF- kB measured by immunohistochemistry assay. Results: There was a significant difference on the Independent T-Test that showed an increase in expression of TGF-β1 and Smad-4 expression and a decrease in expression of NF- kB p= 0.003 (p<0,05) from a group of patients who got long-term oral administration of tamsulosin 0.4 mg, compared with a group of patients who didn’t get any treatment. Conclusion: Long-term tamsulosin would induce an apoptotic process in the prostate cells shown by the activity of TGF-β1, Smad-4, and NF- kB. Keywords: BPH, tamsulosin, TGF-β1, Smad-4, NF- kB, apoptosis
##plugins.themes.bootstrap3.article.details##
BPH, Tamsulosin, TGF-β1, Smad-4, NF- kB, Apoptosis
Purnomo BB. Dasar dasar Urologi. 1st ed. Malang: Sagung Seto; 2011. 125–130 p.
Roehrborn CG. Pathology of benign prostatic hyperplasia. Int J Impot Res. 2008;20(SUPPL. 3).
Parsons JK. Handbook of Urology. 2013.
Dhingra N, Bhagwat D. Benign prostatic hyperplasia: An overview of existing treatment. Indian J Pharmacol. 2011;43(1):6.
Daryanto B, Ali M, Purnomo BB, Mintaroem K. The effect of long-term treatment with an alpha-adrenergic receptor antagonist on contractility of smooth muscle , mRNA , calcium level , and protein kinase C alpha enzyme of prostate in men with benign prostatic hyperplasia. 2019;12(4).
Youm YH, Yoon YD, Woo JH, Yoo TK. Apoptosis Induction and Clusterin Expression of NRP-152 Cells by Tamsulosin. J Korean Cont Soc [Internet]. 2006;10(2):132.
Sagala, Asian E; Daryanto B, Solimun. Pengaruh Antagonis Reseptor Adrenergik-α.Tamsulosin Jangka Panjang Terhadap Apoptosis Sel Otot Polos Prostat Pasien BPH.2016.
Degterev A, Boyce M, Yuan J. A decade of caspases. Oncogene. 2003;22(53 REV. ISS. 7):8543–67.
Zeng L, Rowland RG, Lele SM, Kyprianou N. Apoptosis Incidence and Protein Expression of p53, TGF-β Receptor II, p27Kip1, and Smad4 in Benign, Premalignant, and Malignant Human Prostate. Hum Pathol. 2004;35(3):290–7.
Arsura M, Wu M, Sonenshein GE. TGFβ1 inhibits NF- kB/Rel activity inducing apoptosis of B cells: Transcriptional activation of IκB. Immunity. 1996;5(1):31–40.
Anglin IE, Glassman DT, Kyprianou N. Induction of prostate apoptosis by α1-adrenoceptor antagonists: Mechanistic significance of the quinazoline component. Prostate Cancer Prostatic Dis. 2002;5(2):88–95.
Pang L, Qiu T, Cao X, Wan M. Apoptotic role of TGF-β mediated by Smad4 mitochondria translocation and cytochrome c oxidase subunit II interaction. Exp Cell Res. 2011;317(11):1608–20.
Derynck R, Zhang Y, Feng X-H. Smads: Transcriptional Minireview Activators of TGF-b Responses to be required for ligand-induced transcription. Since coexpression of a receptor-activated Smad with Smad4 activates transcription and dominant-negative interfer. Cell. 1998;95:737–40.
Arsura M, FitzGerald MJ, Fausto N, Sonenshein GE. Nuclear factor-kappaB/Rel blocks transforming growth factor beta1-induced apoptosis of murine hepatocyte cell lines. Cell Growth Differ. 1997;8(10):1049–59.
Viatour P, Merville MP, Bours V, Chariot A. Phosphorylation of NF- kB and IκB proteins: Implications in cancer and inflammation. Trends Biochem Sci. 2005;30(1):43–52.
Kumar R, Verma V, Sarswat A, Maikhuri JP, Jain A, Jain RK, et al. Selective estrogen receptor modulators regulate stromal proliferation in human benign prostatic hyperplasia by multiple beneficial mechanisms—action of two new agents. Invest New Drugs [Internet]. 2012;30(2):582–93.
Verma IM. Nuclear factor NF- kB proteins: Therapeutic targets. Ann Rheum Dis. 2004;63(SUPPL. 2):57–61.
Okamoto T, Sanda T, Asamitsu K. NF-kappa B signaling and carcinogenesis. Curr Pharm Des [Internet]. 2007;13(5):447–62.
Schuster N, Krieglstein K. Mechanisms of TGF-β-mediated apoptosis. Cell Tissue Res. 2002;307(1):1–14.